HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiantai Zhang Selected Research

Spinal Injections

1/2020Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiantai Zhang Research Topics

Disease

4Neoplasms (Cancer)
05/2021 - 02/2019
4Arthritis (Polyarthritis)
01/2018 - 03/2015
3Inflammation (Inflammations)
04/2020 - 08/2011
3Pain (Aches)
04/2015 - 02/2013
3Atherosclerosis
09/2011 - 10/2006
2Cognitive Dysfunction
04/2019 - 01/2018
2Alzheimer Disease (Alzheimer's Disease)
04/2019 - 01/2018
2Rheumatoid Arthritis
03/2015 - 02/2013
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2021
1Multiple Sclerosis
11/2021
1Disease Progression
11/2021
1Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021
1Lymphoma (Lymphomas)
05/2021
1Colitis
05/2021
1Sepsis (Septicemia)
06/2020
1Autoimmune Diseases (Autoimmune Disease)
04/2020
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
04/2020
1Neuralgia (Stump Neuralgia)
01/2020
1Hyperalgesia
01/2020
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2015
1Experimental Arthritis
07/2014
1Carcinoma (Carcinomatosis)
04/2011
1Ventricular Remodeling
05/2010
1Myocardial Infarction
05/2010
1Parkinson Disease (Parkinson's Disease)
08/2008

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
12/2019 - 08/2008
3Therapeutic UsesIBA
06/2020 - 07/2014
3methyl salicylate (Linsal)FDA Link
01/2018 - 07/2014
2Phosphotransferases (Kinase)IBA
01/2022 - 04/2020
2Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2011
2CytokinesIBA
04/2020 - 08/2011
2LigandsIBA
04/2019 - 10/2006
2Amyloid beta-PeptidesIBA
01/2018 - 01/2015
2SalicylatesIBA
03/2015 - 02/2013
2LipopolysaccharidesIBA
03/2015 - 08/2011
2oxidized low density lipoproteinIBA
09/2011 - 10/2006
1nintedanibIBA
01/2022
1Interleukin-18 (Interleukin 18)IBA
11/2021
1Pathogen-Associated Molecular Pattern MoleculesIBA
11/2021
1Pattern Recognition ReceptorsIBA
11/2021
1InflammasomesIBA
11/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
05/2021
1ibrutinibIBA
05/2021
1triptolideIBA
05/2021
1Janus KinasesIBA
04/2020
1InterferonsIBA
04/2020
1OxazoloneIBA
04/2020
1tyrosine receptor (receptor, tyrosine)IBA
04/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2020
1Analgesics (Analgesic Drugs)IBA
01/2020
1AlkaloidsIBA
01/2020
1isotalatizidineIBA
01/2020
1Dynorphins (Dynorphin)IBA
01/2020
1Janus Kinase 2IBA
12/2019
1Scopolamine (Hyoscine)FDA Link
04/2019
1IsoflavonesIBA
04/2019
1Tyrosine Kinase InhibitorsIBA
02/2019
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2015
1ethyl salicylateIBA
02/2013
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
09/2011
1OxidesIBA
09/2011
1Interleukin-6 (Interleukin 6)IBA
08/2011
1Antineoplastic Agents (Antineoplastics)IBA
04/2011
1Advanced Glycation End ProductsIBA
10/2008
1Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
10/2008
1baicaleinIBA
08/2008
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
08/2008

Therapy/Procedure

2Therapeutics
05/2021 - 05/2010
1Punctures
06/2020
1Ligation
06/2020
1Intraperitoneal Injections
06/2020
1Spinal Injections
01/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2015